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Abstract
Although alveolar epithelial type II cells (AECII) perform substantial roles in the maintenance of alveolar integrity, the extent
of their contributions to immune defense is poorly understood. Here, we demonstrate that AECII activates alveolar
macrophages (AM) functions, such as phagocytosis using a conditioned medium from AECII infected by P. aeruginosa. AECII-
derived chemokine MCP-1, a monocyte chemoattractant protein, was identified as a main factor in enhancing AM function.
We proposed that the enhanced immune potency of AECII may play a critical role in alleviation of bacterial propagation and
pneumonia. The ability of phagocytosis and superoxide release by AM was reduced by MCP-1 neutralizing antibodies.
Furthermore, MCP-1
2/2 mice showed an increased bacterial burden under PAO1 and PAK infection vs. wt littermates. AM
from MCP-1
2/2 mice also demonstrated less superoxide and impaired phagocytosis over the controls. In addition, AECII
conditioned medium increased the host defense of airway in MCP-1
2/2 mice through the activation of AM function.
Mechanistically, we found that Lyn mediated NFkB activation led to increased gene expression and secretion of MCP-1.
Consequently Lyn
2/2 mice had reduced MCP-1 secretion and resulted in a decrease in superoxide and phagocytosis by AM.
Collectively, our data indicate that AECII may serve as an immune booster for fighting bacterial infections, particularly in
severe immunocompromised conditions.
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Introduction
Alveolar type II epithelial cells (AECII) maintain alveolar
integrity by forming the alveolar barrier, producing surfactants
and repairing injured type I epithelium [1]. Recently, several
reports indicate that AECII may be an integral part of the lung
innate immunity, acting to intensify the function of dendritic cells
[2] and alveolar macrophages [3]. AECII may also perform other
important functions such as cytokine secretion [4], antigen
presentation [5] and enhancement of macrophage phagocytosis
through surfactant proteins such as SP-D [6]. However, the role of
AECII in infection immunity and underlying mechanism is largely
unknown. Understanding the additional immunological role of
AECII is important because professional immune cells such as
alveolar macrophages (AM) in some cases rarely succeed in
eradicating pathogens on their own. This is the case with
Pseudomonas aeruginosa, an opportunistic gram-negative bacterium
accounting for 10.1% of nosocomial infections. Clinical reports
have shown that P. aeruginosa infects about 97.5% of Cystic Fibrosis
children at age of 3 years [7]. P. aeruginosa infection is a main
clinical problem in various immunodeficiency conditions such as
HIV, severe burns, and cancers. This bacterium exhibits resistance
to conventional antibiotics through a variety of virulence factors
and there are no effective vaccines, making it difficult to eradicate
once it colonizes the respiratory tract [8,9].
Previous studies demonstrated that AECII cells can stimulate
AM immunity in the lung of either mice or rats to boost the host
defense against P. aeruginosa [4]. The caveats are that the studies
have focused on whole animals to identify the cell types responsible
for secreting chemokines by co-localization techniques. Also, the
specific cell type involved in the immune activity has not been
clearly defined. Although the main chemotactic factor released
from AECII is likely to be MCP-1 [4], it is hard to prove in vivo
whether AECII are the actual secreting cells. Also, the specific role
of MCP-1 derived from AECII is less clear. A recent study
suggested that isolated human AECII may secrete chemokines
such as MCP-1 at higher amounts than AM primed with
lipopolysaccharide (LPS) [10]. However, the specific immune
response by characteristically defined AECII to P. aeruginosa
infection remains to be determined. Furthermore, the underlying
mechanism governing AECII mediated host immunity and
regulatory factors involved in secretion of MCP-1 are not clearly
established. Thus, it is necessary to investigate and fully establish
the immune role of AECII.
To determine the immunological function of AECII, we chose
to investigate if AECII have a role in activating AM in response to
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e4891P. aeruginosa infection. We used our primary cell culture models as
well as mouse models including knockout mice to identify the
signaling proteins that may regulate AM function and by
identifying the cytokine products derived from AECII. We have
shown here the importance of MCP-1 secreted by AECII in the
activation of AM. Using MCP-1
2/2 mice, we also confirmed that
MCP-1 has a crucial activity in increasing AM functionality
through enhancing phagocytosis, increasing superoxide produc-
tion, balancing inflammatory response and thereby optimizing
host defense. In addition, we delineated the mechanism that
regulates MCP-1 secretion in AECII, in which we found that Lyn,
a critical Src family member, can increase MCP-1 secretion by
activating the NF-kB pathway.
Results
Our objective was to test whether AECII in a culture system can
boost the immune function of AM. Through co-culturing
macrophages with lung epithelial cells, macrophages were
significantly activated, demonstrating multiple functional activities
including enhanced migration and actin reorganization (Figure
S1A, B). To investigate whether secreted (soluble) substances are
major mediators, we collected a conditioned medium from
primary mouse AECII following PAO1 infection for 1 h and
added to primary AM culture. After 24 h, AM activity was
detected by three measurements: migration (Figure 1A), phago-
cytosis (Figure 1B) and superoxide production (Figure 1C). Our
data indicates that the three AM function parameters were
significantly increased by the AECII conditioned medium
compared to the control medium from AECII without infection
(P,0.05, Student’s t test). The activated AM also showed more
significant morphological changes with membrane projections
such as lamellipodia and filopodia by confocal microscopy
(Figure 1D). Moreover, we demonstrated apparent morphology
alterations by scanning electron microscopy (SEM) (Figure 1E).
Although we found that AECII have a role in activating AM, it is
possible that AM themselves can be activated by P. aeruginosa,
which enhances the function of resting AM through an autocrine
loop. Thus, we evaluated whether the activated AM can bolster
immunity by stimulating other naı ¨ve AM. We co-incubated resting
AM with a conditioned medium that was derived from AM
following P. aeruginosa time course infection. As expected, we have
found that the AECII conditioned medium indeed showed greater
increases in AM migration and superoxide production compared
to the AM-conditioned medium, particularly at earlier times (6 h,
Figure S1C). However, AM also secreted comparable MCP-1
possibly through autocrine activation at 24 h.
To investigate how AECII can activate AM, we studied the
possible involvement of various cytokines and chemokines. Thus
we performed an in vitro experiment with isolated primary mouse
AECII to measure cytokines in the conditioned medium of AECII
infected by P. aeruginosa, which showed a significant increase in
MCP-1, IL-1b, MIP-2a, and TNF-a (Figure 2A, B). We also
showed that MCP-1 can transmit cellular signals to AM (4), and
may be a dominant cytokine in cultured AECII cells. The
secretion of MCP-1 is time dependent (Figure 2B). Also, we
detected increased expression of MCP-1 and CCR2 (MCP-1
receptor) expression on AECII cells by western blotting
(Figure 2C). We further confirmed that the MCP-1-secreting cells
expressed SP-C (a marker of AECII) by co-localization with
confocal microscopy (Figure 2D). Similar results showing cytokine
secretion by AECII were also found in murine lung type II cell line
MLE-12 cells [11] (Figure S2A). We then infected mice to
investigate MCP-1 secretion in response to P. aeruginosa infection in
Figure 1. Conditioned medium from AECII by PAO1 infection activated AM (12 h). (A) Increase of AM migration as determined by
chemotaxic chamber methods (see Material and Methods). Migration index was calculated based on conditioned medium or control medium. (B)
Increase in phagocytosis of AM as detected by CFU (colony forming units). (C) Increase in superoxide production of AM analyzed by H2DCF
fluorescence (Molecular Probes). (D) The morphology of the activated AM is shown typically with lamllipodium and filopodium by confocal
microscopy. (E) The morphology of the activated AM is further evidenced by high resolution and magnification Scanning Electron Microscopy (SEM).
Statistical analysis was done by comparing mean individual values versus controls using student’s t test, *p,0.05 (95% Confidence Interval, CI). The
results are representative of three experiments.
doi:10.1371/journal.pone.0004891.g001
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group) were infected with PAO1 intranasally, and broncho-
alveolar lavage (BAL) was performed 18 h post infection. MCP-1
level was found to be increased as measured by immunohisto-
chemistry in lung tissue, and PAO1 infected mice showed a
significant increase in MCP-1 compared to uninfected controls
(Figure 2G). Furthermore, the MCP-1 expression was demon-
strated on AECII cells of human lung tissues from CF patients
with P. aeruginosa infection (Figure 2E), suggesting that MCP-1
actually participated in host defense in infected humans. We
showed that lipid rafts in AECII are reorganized into aggregates
(platforms for cell signaling) following acute infection by P.
aeruginosa [12], which is consistent with several studies regarding P.
aeruginosa or other microorganisms [13–15]. P. aeruginosa has type
three secretion system (T3SS) exoenzymes ExoS, ExoT, ExoU and
ExoY, among which ExoS and ExoT are similar in the sequence
and function for ADP ribosyltransferase and GTPase-activation
protein activities [16]. The raft aggregates are differentially
induced by various T3SS mutants or a pili deficient mutant
[12]. Since there were some rafts outside the P. aeruginosa,w e
further quantified raft aggregates using Image J software and
showed that P. aeruginosa infection induced strong raft aggregates,
which were also associated with P. aeruginosa (Figure 2F). In
addition, controls without infection did not show raft aggregates,
thus the aggregates of lipid rafts may be a specific response to P.
aeruginosa. Next, we used various inhibitors to define the raft
pathway in P. aeruginosa adhesion and internalization into AECII.
Among the various inhibitors we have tested, we found that the
lipid raft inhibitor (mbCD), Lyn tyrosine kinase inhibitor (PP2),
Akt inhibitor, and NF-kB inhibitor effectively blocked adhesion
and internalization of P. aeruginosa, whereas the ceramide inhibitor
(blocking sphingolipid pathway) only reduced internalization
without affecting adhesion (Figure 2G, Table 1 and Figure S2B).
This data suggests that ceramide and cholesterol may differentially
Figure 2. MCP-1 from AECII was a major regulator by PAO1 infection. (A) Increase of various proinflammatory factors at 24 h following
stimulation with the conditioned medium from AECII infected by PAO1. (B) MCP-1 was significantly increased in a time dependent manner by the
conditioned medium. (C) Both MCP-1 and its receptor of CCR2 were increased in AECII by PAO1 infection detected by western blotting. (D) Primary
AECII secreted MCP-1 that was colocalized (arrows) with SP-C (a specific marker of AECII) as analyzed by immuno-fluorescence (anti-pro-SP-C from Dr.
Jeffrey Whitsett). (E) Increase of MCP-1 expression in the AECII cells in human samples from Cystic Fibrosis (CF) patients (one of the 6 representative)
stained by immunofluorescence. (F) Lipid raft quantification using Image J software. The colocalized pixels were identified and threshold defined vs.
background. The image was converted into binary format and the ‘‘analyze particle tool’’ used to identify raft ranging in size of 15–255 pixels
(correlates with 50–200 nm). (G) Blockade of lipid rafts with mbCD significantly reduced the secretion of MCP-1 in the lung vs. the control. The frozen
sections for the lung tissue of C57BL6 mice (5 mice/group) were stained by anti-MCP-1 antibodies from Santa Cruz (arrows showing the positive
staining). The results are representative of three experiments.
doi:10.1371/journal.pone.0004891.g002
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dissect the mechanism, we intranasally instilled cholesterol
chelator mbCD into mouse lungs and found a reduction in
bacterial internalization and MCP-1 secretion was also partially
hindered (Figure 2G).
The expression of CCR2 (MCP-1 receptor) was increased in
AM treated with AECII conditioned medium as determined by
western blots (Figure 3A), indicating a functional involvement of
this receptor in the pathway. Next, blocking of MCP-1 with
neutralizing antibodies for 30 min before infection also down-
regulated CCR2 compared to no antibody controls using
fluorescent microscopy (Figure 3B). To further confirm the role
of MCP-1, we added commercially available purified MCP-1
peptide (Calbiochem) directly to AM and found direct correlation
between MCP-1 presence and AM activation, including superox-
ide production (Figure 3C). Furthermore, by blocking with MCP-1
neutralizing antibodies for 30 min before PAO1 infection, we
observed that the mice showed more severe infection with
increased bacterial burden (CFU/1 mg lung homogenates)
compared to that in the wt mice (Figure 3D). In addition, the
MCP-1 antibodies reduced superoxide production (Figure 3E) and
phagocytosis by AM (Figure 3F) against the Ig isotype control. To
ascertain the immune activity of AECII, we determined the
immune symbolic markers, such as IL-12R and MHC Class II
antigen by immunofluorescence. We showed that activated AECII
expressed enhanced levels of MHC class II antigen as well as IL-
12R and IL-17R (Figure S3A, B).
To further determine the role of MCP-1 as an immune
stimulator, MCP-1 deficient mice (MCP
2/2 mice) were used to
Table 1. Inhibition of adhesion and internalization of
bacterium.
Regent Adhesion Internalization
Control 26 0.89
mbCD 2.2 0.07
Ceramide inhibitor 18 0.13
PP2 4.2 0.28
*Raft blockers (mbCD cholesterol chelator, and ceramide inhibitor [Racemic]
3 mM Alexis) hampered PA internalization. PP2 is Lyn inhibitor.
doi:10.1371/journal.pone.0004891.t001
Figure 3. MCP-1 receptor was increased along the enhanced immune function and MCP-1 antibody alleviated the infection. (A) The
receptor of MCP-1 (CCR2/CKR2) was also increased in AECII by PAO1 infection detected with western blotting. (B) CCR2 expression following PAO1
infection was reduced by pre-incubating with MCP-1 antibodies (30 min) and determined by immunofluorescence. (C) Increase in superoxide release
was measured using H2DCF by direct addition of the commercially available MCP-1 peptide. (D) BAL CFU from mice was increased by neutralizing
antibodies against MCP-1 before PAO1 infection. (E) Superoxide was reduced in the AM from mice following instillation of MCP-1 antibodies as
measured by NBT assay. (F) The AM from the same mice also demonstrated decreased phagocytosis ability. Statistical analysis was performed as
above (** p,0.01, 99% CI). The results are representative of three experiments.
doi:10.1371/journal.pone.0004891.g003
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role during P. aeruginosa infection. This can also distinguish the
relative contributions of MCP-1 to immune defense against P.
aeruginosa infection. We found that MCP-1
2/2 mice showed
increased bacterial burden in the lung (Figure 4A). A significant
decrease in the superoxide production in AM was also noted
(Figure 4B). Furthermore, the lung from MCP-1
2/2 mice showed
increased lung cell death (showing decreased mitochondrial
potential) following infection by P. aeruginosa (Figure 4C). Lung
injury was also present as wet/dry ratio was increased by infection
in the mice (data not shown). We also showed that isolated AM
from MCP-1
2/2 mice after bacterial infection had increased
ability to phagocytose opsonized-E coli particles (Figure 4D),
indicating that the AM have not been saturated in uptaking
bacteria (probably due to reduced migration) during in vivo
infection. Interestingly, we noted that the lung injury is correlated
with the increase in a number of pro-inflammatory factors such as
MIP-2a (but probably also due to the loss of MCP-1) than the
wild-type control (Figure 4E). Also, there was an increased
neutrophil infiltration in the BAL (not shown). These data suggest
that MCP-1 may be crucial in maintaining a fine balance between
pro-inflammatory and anti-inflammatory cytokines, which is
important for combating bacterial invasion as well as minimizing
acute lung injury. Also, we instilled the conditioned medium into
MCP-1
2/2 mouse lungs, which increased the host defense
compared to the control medium (Figure 4F). These data critically
confirm that MCP-1 is a potent immune regulator and
inflammation controller in the airway spaces.
Because raft signaling is partially dependent on T3SS, we
attempted to define whether deletion in a single exoenzyme
impacts the MCP-1 secretion by AECII. PAO1 wt and several
toxin deficient strains (PAO1 DExoS, DExoT, PA14 DExoU and
Figure 4. MCP-1
2/2 mice demonstrated functional involvement with P. aeruginosa infection. (A) MCP-1
2/2 mice showed more severe
infection by P. aeruginosa (strains PAO1 and PAK) with an increase in bacterial burdens. Data were derived from a group of 5 infected and control
mice (same in the figure). (B) Superoxide production was significantly altered in AM from MCP-1
2/2 mice following infection identified by NBT assay.
(C) A significant increase in apoptotic cell death was observed in MCP-1
2/2 mice by bacterial infection. The data identified the loss of mitochondrial
potential in MCP knockout mice, indicating increased cell apoptosis. (D) An increase opsonic phagocytosis with E. coli particles was found in AM
derived from MCP-1
2/2 mice following infection. (E) An increase in inflammatory chemokine MIP-2a in the MCP-1
2/2 mice after PAO1 infection. The
mRNA expression is shown in an agarose gel using semi-quantitative RT-PCR. (F) Conditioned medium partially restored the immune defense against
P. aeruginosa infection in MCP-1
2/2 mice. Statistical analysis was as above. The results are representative of two experiments.
doi:10.1371/journal.pone.0004891.g004
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data indicates that the various T3SS mutant strains influenced
secretion of MCP-1 compared to PAO1 wt (except DExoT), the
highest inducer being DExoS as determined by RT-PCR and
ELISA (Figure 5A, B). Consequently, the conditioned medium
from mutant strain DExoS induced greater AM activation
(phagocytosis) than PAO1 wt (Figure 5C). By contrast, DExoS
strain resulted in lesser superoxide in AM than PAO1 wt strain
(Figure 5D). One possible explanation for this result is that loss of a
particular exoenzyme may reduce the bacterial invasive ability,
permitting the host to mount a better defense. The controls with
normal medium, DMSO (for inhibitor dilution) and PAO1
supernatant induce measurable but lesser response than that of
live PAO1 (Figure 5D). We next examined whether live P.
aeruginosa is necessary to induce MCP-1 secretion by AECII and to
turn the cells immunologically more potent. Using dead PAO1
(heating at 60uC for 1 h), supernatant, LPS and live PAO1 wt (in
the same amount of bacteria and same number of cells), we
compared differences in MCP-1 secretion during infection of
AECII. We found that live PAO1 increased MCP-1 secretion
more so than did dead PAO1, supernatants, and LPS. The
conditioned medium from live infection also induced the strongest
activation of AM (Figure 5E). Thus, it is likely that live bacterial
infection initiated stronger stimulation of AECII secretion than
dead bacterium or its components.
Since Src tyrosine kinase Lyn is located in the inner cytoplasm
membrane of the cell, in the general proximity to lipid rafts, we
investigated the role of several members of this family and
discovered that Lyn (p53/56) played a major role in P. aeruginosa
infection. We have demonstrated that Lyn was activated in A549
cells following exposure to P. aeruginosa [12]. Lyn phosphorylation
was measured by immunoblotting with phosphor-Src antibodies
on immunoprecipitated Lyn protein from cell lysates. Pre-
treatment of AECII with 5 nM PP2 (synthetic inhibitor for Lyn)
blocked MCP-1 secretion (Figure S2B).
To elaborate the role of Lyn in MCP-1 production, Lyn siRNA
transfection was performed to assess the effect of Lyn on P.
aeruginosa invasion (transfection efficiency .95%) [17], and our
data show that MCP-1 was markedly decreased by Lyn siRNA
(Figure 6A). Importantly, the role of Lyn was confirmed using
Lyn
2/2 mice, demonstrating significantly reduced MCP-1 by
PAO1 and PAK infection vs. Lyn wt mice as determined by
mRNA expression (Figure 6B). Reduction of MCP-1 secretion was
also observed in Lyn
2/2 mice as determined by ELISA
(Figure 6C), whiles there is no difference between wt and KO
mice in non-treated condition (data not shown). To probe
downstream effectors in this pathway, we investigated NF-kB
activation in response to P. aeruginosa infection. We evaluated this
signaling process and our data showed that blocking of Lyn using
dominant negative transfection of LynK275D construct [12]
Figure 5. Exoenzymes were involved in MCP-1 secretion. (A) DExoS strain induced increased MCP-1 mRNA and protein expression by MLE-12
lung epithelial cells assessed by RT-PCR and ELISA (B). (C) DExoS strain resulted in increased phagocytosis by AM than PAO1 wt. (D) DExoS strain
induced decreased superoxide in AM (PAO1 sup: PAO1 supernatant; fMLP 5 mM from Sigma). (E) Less potency by dead PAO1, PAO1 supernatant and
LPS (P. aeruginosa lipopolysaccharide, serotype 10, 200 ng/ml, Sigma) in inducing MCP-1 than live PAO1. (F) MCP-1 alone also induced MCP-1
secretion in primary AECII. Statistical analysis was performed as above. The results are representative of two experiments.
doi:10.1371/journal.pone.0004891.g005
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to Lyn wt control transfectants (not shown). Using NF-kB
luciferase plasmid, we found a pronounced increase in luciferase
activity with conditioned medium obtained from PAO1 infected
AECII cells, but this was blocked by LynK275D transfection
(Figure 6D). We also observed similar Lyn-K275D-based inhibi-
tion in functional roles of AM. These findings suggest that Lyn
signaling is linked to both the secretion of AECII and its functional
role of AM. Finally, we also demonstrated that Lyn overexpression
and increased phosphorylation in the human lung tissue of CF
patients against the normal control (Figure 6E). Our data indicate
that Lyn activation might have occurred during CF disease
process, thus it is reasonable to propose that Lyn may serve as a
therapeutic target for controlling the disease.
The AECII – AM cross-talk is presented in a simplified model
(Figure 7). Bacterial infection activates AECII cells that secrete
chemokines (MCP-1). MCP-1 transmits signals to activate AM,
which migrate towards infection sites and eliminate the pathogen.
Lyn and lipid rafts may regulate MCP-1 and AM activation. In
addition, the host defense may be balanced through the fine
regulation by both Lyn and MCP-1.
Discussion
Previous reports, either from animal studies or from work with
lung epithelial cells, indicate that epithelial cells can secrete
cytokines to increase AM immune function in combating P.
aeruginosa infection [2,4]. Our studies use both isolated AECII
mouse cells and animals (including knockout mice) and
demonstrate that the chemokine MCP-1 can up-regulate the
innate immunity of AM. Innate immunity of the respiratory
system in normal individuals is sufficient to prevent P. aeruginosa
infection, but is unable to eradicate the bacteria in immunode-
ficient individuals, resulting in recurrent infection or acute
dissemination. Activating the immunological functions of AECII
may lend much-needed help in fighting microorganisms such as
P. aeruginosa. The results from our studies demonstrate that MCP-
1 production was dramatically increased after infection of
AECII. Further, we have shown that direct application of
synthetic MCP-1 peptide also boosts AM functions, albeit in a
less potent way compared to induction by P. aeruginosa-infected
medium. In addition, the instillation of MCP-1-neutralizing
antibodies into mouse lungs blocks cytokine secretion and
induces more severe pneumonia, indicating a critical functional
role of this particular chemokine. The foremost function of these
secreted factors is to recruit AM and boost their microbicidal
activity. Importantly, we show direct evidence from MCP-1
knockout mice, which exhibited reduced clearance of P.
aeruginosa and increased pathological alterations in the lungs. In
contrast, reconstitution of MCP-1 using conditioned medium
partially recovered the inadvertent pathophysiology induced by
P. aeruginosa.
Figure 6. Lyn regulated MCP-1 production by activating NF-kB. (A) MCP-1 secretion was abolished by Lyn siRNA transfection in AECII cells.
(B) Decrease in MCP-1 expression in the lungs. (C) Decrease in MCP-1 expression secretion in BAL fluid (bronchoalveolar lavage) in Lyn
2/2 mice by P.
aeruginosa infection. Data were representative of two experiments with a group of 5 mice (infected and control). (D) Dominant negative Lyn
construct transfection (DN=LynK275D) reduced NF-kB translocation in AECII as determined by a Luciferase NF-kB reporter assay. (E) Increased
expression and activation of Lyn in human lung infected with P. aeruginosa. Tissues were from CF patients and normal controls (showing
representative of 6 samples). Statistical analysis was done as above. The in vitro results are representative of three experiments.
doi:10.1371/journal.pone.0004891.g006
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initiate dynamics that directly or indirectly regulate the down-
stream activities, including cytokine secretion by AECII and
bacterial phagocytosis by AM. We showed that lipid rafts in
AECII are reorganized following acute infection by P. aeruginosa
[12], which is consistent with several studies regarding P. aeruginosa
or other microorganisms [13–15]. Thus we reasoned that AECII
initial contact with the invading P. aeruginosa occurs through lipid
rafts. Raft signaling may be beneficial to the host against P.
aeruginosa [18], although some reports indicate that other
pathogens (e.g., HIV) may use lipid rafts to subvert the innate
immunity functions [19]. We also suggest that lipid rafts may
directly associate the signaling pathway in activating AM [17].
Using ImageJ software, we provide quantitative evidence that lipid
raft aggregates have a specific role in host defense against
infection. Our data indicate that ceramide only associates with
P. aeruginosa adhesion, while cholesterol impacts both adhesion and
internalization to AECII cells. Our study also substantiates the role
of lipid rafts in cytokine secretion, consistent with previous work in
this field showing that TNF-a secretion is mediated by recruiting
syntaxin-4 to lipid rafts [20]. Previous studies showed that various
mechanisms such as JNK, TNF-a and IL1-b are implicated in
boosting MCP-1 secretion [21].
Importantly, we have identified that Lyn is crucial in host
defense against bacterial infections. Lyn up-regulates MCP-1
secretion and promotes AM activity. Although Lyn was previously
shown to be involved in the progression of Friend virus-induced
erythroleukemia [22], Lyn’s role in secretion of cytokines is not
known. We also showed that the Lyn mediated regulation of
MCP-1 secretion may be through the activation of NF-kB, which
is a key transcriptional factor for inducing gene expression of many
immune molecules including MCP-1. Our data are consistent with
a report from Kowalski et al [13], who showed that P. aeruginosa
infection of respiratory epithelial cells induced NF-kB nuclear
translocation and blocking rafts using cholesterol chelating agents
prevented this signaling. Lyn may also be able to increase reactive
oxygen species production and release through the activation of
PI3K and Akt [23–25] or other cellular signals (i.e., p47Phox,
M.W., S.K., unpublished observations). Mechanistically, we
identified a potential Lyn regulation site via H4 hyperacetylation
at location K16 (unpublished). Additionally, we found that these
responses may involve bacterial components including pili and
ExoS. This is interesting because ExoS may be an important
component of exoenzymes, responsible for intoxicating host
defense mechanisms for bacterial benefit. In fact, pili as the
surface structure of the bacterium may directly target lipid rafts to
impact host signaling (not published). Also, reduction of MCP-1
production was seen when cells were challenged with a pili-
deficient strain but increased MCP-1 secretion was noticed using
the pili-corrected strain. Finally, our study also demonstrates that
although dead bacteria or their partial products (LPS and
supernatant) may have effects on igniting host defense, it is the
live bacterium that stirred the strongest inflammatory response.
Whether or not AM are crucial for mitigating P. aeruginosa
infection has been controversial. Our study has reaffirmed that
AM are an important entity for exerting immune defense during
acute P. aeruginosa infection. Our data indicates that activated AM
are essential for phagocytosis of invading bacteria and scavenging
dead bodies of neutrophils, evidenced by greater neutrophil
penetration and pro-inflammatory cytokine response in Lyn
2/2
mice. The increased superoxide in AECII-activated AM can be
utilized to kill the engulfed bacteria, particularly important during
high doses of bacterial infection. Our results indicate that AM
alone may be less effective, while cytokines or chemokines derived
from AECII or other unidentified mechanisms may give AM an
added power that is required for clearance of invading
microorganisms (Figure 7). However, the effects of AECII immune
roles may impact other cell types such as neutrophils and
lymphocytes, which may be interesting directions for future
studies.
The Lyn axis maintains a fine balance involving several Src
members or signaling proteins. Lyn through the ITAM motif up-
regulates Syk function, which has been shown as important for
opsonic phagocytosis by monocytes through FccII mechanisms
[26]. Lyn also has a positive role in ITIM motif that increases SH2
inositol phosphatase (SHIP), which may down-regulate inflamma-
tory cytokines during acute infections [27–29]. Phagocytosis of the
bacterium is dependent on many virulence factors as well as the
host mediators. One of the major virulent effects of T3SS is
disruption of cortical actin in phagocytic cells. We have reported
earlier that a similar mechanism also exists in alveolar epithelium.
Our recent study showed that T3SS is also involved in the
phagocytosis of P. aeruginosa into AM [17]. P. aeruginosa releases
these toxins directly into the host cytoplasm. Once activated, the
ExoS and ExoT affect small GTPases by ADP ribosylation and
GTPase activity, thereby deregulating cytoskeletal polymerization
[30]. P. aeruginosa uses this mechanism to escape from phagocytosis
and survive in the airways. Whether ExoS and ExoT have any
direct effect on host cytokine secretion is less clear. Current studies
demonstrate that secretion of MCP-1 may be inhibited by ExoS,
as an ExoS-deficient strain induced even stronger secretion. Strain
of DExoS also reduced superoxide release, but by an unknown
mechanism.
Together, our study not only delineates the immunological role
of AECII but also suggests that AM, aided by AECII, are
important for combating P. aeruginosa infection. Specifically, we
identified that the secreted MCP-1 was a major booster for AM
Figure 7. Diagram delineates a pathway involved in the AECII
immune role against P. aeruginosa infection. AECII cells initiate
an immunity to boost AM anti-infection function. The chemokine MCP-
1 seems a crucial factor in this cell-cell cross-talk, which may be initiated
by lipid rafts and regulated by Lyn. While boosting MCP-1 production
through NFkB pathway, Lyn may contain excessive production of MIP-
2a as another mechanism to keep the inflammation response in control.
doi:10.1371/journal.pone.0004891.g007
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suggest that both Lyn and MCP-1 have crucial roles in balancing
inflammatory response to bacterial challenge through interaction
with various cell signaling proteins. The results from the current
studies may open new avenues for the development of much-
needed therapeutics for treating P. aeruginosa infection.
Methods
Animals. C57BL6 mice were purchased from the Jackson
Laboratory. Lyn
2/2 mice based on J129/C57BL6 mice (6–8
weeks, female and male) were as described previously [31,32].
MCP-1 mice were previously described [33], which were
purchased from the Jackson Laboratory. The animal
experiments have been approved by UND IACUC committee
and were performed in accordance to the animal use and care
guidelines. We anesthetized mice with 45 mg/kg ketamine plus
5 mg/kg diazepam, and intranasally instilled 0.1610
7 (PAK) to
0.5610
8 (PAO1) colony-forming units (CFUs) of P. aeruginosa for
various times. After bronchoalveolar lavage (BAL), the trachea and
lung were excised for homogenization or inflated with 50% OCT
or formalin fixation. Intranasal instillation of the conditioned
medium derived from P. aeruginosa infection with different bacterial
strains was performed similarly as above. In selected experiments
to check the efficiency of instillation, we used intratracheal
instillation and ventilation procedures to confirm evenness of
distribution in the lung.
Cell culture. Rat AECII cells were isolated as previously
described and used within 2 days to preserve type II characteristics
[12,34,35]. Mouse AM were isolated by bronchoalveolar lavage
(BAL) concurrent to AECII isolation as described [17,36,37].
AECII cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM) and AM in RPMI 1640 medium supplemented with
10% newborn calf serum and penicillin/streptomicin antibiotics in
5% CO2 incubator. A549, MLE-12 and MHS cells were obtained
from ATCC and maintained following the manufacture’s
instructions. For optimal seeding density, the cells were counted
using neubauer chamber and dead cells were excluded by the
trypan blue exclusion assay. We generated and collected
conditioned medium from primary mouse AECII following
PAO1 infection for 1 h and cultured another 24 h (after adding
100 mg/ml polymycin to kill the surface bacteria). The control
medium without infection was collected for use. After co-culturing
primary AM with the conditioned medium for 24 h, AM activity
was detected by functional measurements as described in the
related sections.
Bacterial strains and infection. PAO1 wt is with an intact
pilC gene and thus with twitching motility provided by Dr. S. Lory
(Harvard) [38]. PAO1 wt GFP, DfliC (flagellin minus), DexoS,
DexoT and DexoU deletion mutant strains, PAK (pili wt), PAK
DpilC (pili deficient) and PAO1 were obtained from Dr. Gerald
Pier (Harvard Medical School) [39]. PA14 wt (DexoS, DexoT,
DexoU and DexoY) were from Dr. E. Drenkard (Massachusetts
General Hospital) [40] and used in selected experiments. Bacteria
were grown overnight in LB medium at 37uC without shaking.
Absorbance at 600 nm was measured for quantification (0.1
OD=1610
8 bacterium/ml).
Immunohistochemistry and immunocytochemistry stain-
ing and confocal imaging. Adherent cells in Labtek chamber
slides or animal/human tissue sections were stained for cell surface
markers using appropriate primary antibodies and double stained
for immunofluorescence with TRITC or FITC conjugated
respective secondary antibodies. The cells were washed, and
pictures taken with Zeiss LSM 510 confocal laser scanning
microscope (Carl Zeiss MicroImaging, Inc, Thornwood, NY). The
human samples were used in accordance to the NIH exempt
guidelines and approved by the UND IRB committee. For live cell
imaging, MatTek glass bottom dishes were used with a portable
incubation chamber to keep cells at 37uC.
RT-PCR analysis
RNA was extracted from Lung homogenates and cells with
Trizol (Invitrogen Corporation) according to the manufacturer’s
instructions. For detected genes, reverse transcription (RT) was
performed using 1.5 mg of RNA, RNase ribonuclease inhibitor,
Oligo dT and cloned AMV reverse transcriptase (Invitrogen
Corporation). cDNA was amplified using gene-specific primers as
summarized in Table 2. PCR products were separated by 1.0%
agarose gel electrophoresis containing ethidium bromide and
visualized under UV light. The results for each gene were
normalized in comparison with GAPDH expression.
Cytokine Immunoassay
Cytokine concentrations were measured by ELISA kit
(eBioscience company) in cell culture medium, BAL fluid and
lung homogenates collected at indicated times after infection.
Briefly, the cells were treated as described as above. On 24 h or
48 h, culture mediums were collected and cells. For BAL fluid, the
trachea was surgically exposed and cannulated, lungs were lavaged
5 times with 1.0 ml volumes of lavage fluid, the lavageates were
pooled, and cells were removed by centrifugation. For lung
homogenates, excised lungs were ground using a sterile glass-
TeflonH in 500 ml PBS. 96-well plates (Corning Costar 9018) were
coated with 100 ml/well of capture antibody in coating buffer and
incubated overnight at 4uC. 100 ml aliquots of serum samples were
added to the coated microtiter wells. The cytokine concentrations
were determined with corresponding detection HRP-conjugated
antibodies. The values were read at 450 nm and analyzed.
Western blot and Co-immunoprecipitation
The sample from cells and lung homogenates were lysed and
quantitated. The lysates were boiled for 5 min, and protease
inhibitors added. The supernatants were collected, and 30 mgo f
each sample were loaded onto 10% SDS-polyacrylamide mini-gels
and electrophoresed to resolve proteins. The proteins were then
transferred to polyvinylidene difluoride membranes (Pierce
Biotechnology) and blocked overnight at 4uC using 5% non-fat
milk blocking buffer western antibody buffer [41,42]. Membranes
were incubated overnight at 4uC with the appropriate first
antibodies diluted 1:1,000 in 5% non-fat milk blocking buffer.
After washing three times with washing solution, the antigen-
antibody complexes were incubated for 2 h at room temperature
with horseradish peroxidase-conjugated secondary antibody
Table 2. Primers for cytokines.
Gene Sense Antisense
IL-6 TTGCCTTCTTGGGACTGATGCT GTATCTCTCTGAAGGACTCTGG
IFN-c TGCATCTTGGCTTTGCAGCTCTTC GGGTTGTTGACCTCAAACTTGGCA
TNF-a ACCGTCAGCCGATTTGCTATCTCA TGGACATTCGAGGCTCCAGTGAAT
IRF-1 CACCATGCCAATCACTCG GGG TAG AGCTGCTGAGTCCA
MCP-1 TCCCAATGAGTAGGCTGGAGAGC CAGAAGGCTTGAGGTGGTTGTG
GAPDH TAAAGGGCATCCTGGGCTACACT TTACTCCTTGGAGGCCATGTAGG
doi:10.1371/journal.pone.0004891.t002
Alveolar Epithelium Immunity
PLoS ONE | www.plosone.org 9 March 2009 | Volume 4 | Issue 3 | e4891(Amersham) diluted 1:2,000. Signals were visualized using
enhanced chemiluminescence detection kit (SuperSignal West
Pico; Pierce).
For co-immuno-precipitation, the supernatants were pre-
cleared with bare protein A/G-Sepharose beads (Pierce) for 1 h
at 4uC and then incubated with anti-MCP-1, anti-NFkB, or anti-
Lyn Abs (Santa Cruz) bound to protein A/G Sepharose beads
overnight at 4uC. The next day, beads were washed three times in
lysis buffer and boiled in SDS sample loading buffer. The proteins
were separated and analyzed by western blotting.
AM migration assay. AM migration was evaluated in either
8 mm transwell cell culture insert or chemotaxis chamber as
described previously [43] using Boyden chamber. Briefly, cells
were plated on the upper chamber and allowed to adhere
overnight. After treatment, the filter was washed in phosphate
buffered saline (PBS) and turned upside down; the migrated cells
in the bottom of the filter were counted using specific red
fluorescence (DiI, Molecular probes) staining followed by confocal
microscopy. Cells were visualized by exciting with 533 nm
wavelength HeNe laser and emission detected in the red spectra
with a long pass filter. At least 100 fields per sample were counted
for statistical purpose.
Fluorescent phagocytosis assay. AM cells were plated in
96 well plates and grown overnight. The cells were treated with
the conditioned medium from AEC II for 2 h. Then FITC labeled
E. coli or GFP PAO1 was used to infect the cells at MOI 1:10.
After 1 h incubation at 37uC the wells were washed and treated
with Polymixin 100 mg/ml for 1 hr to kill any remaining
extracellular bacteria. The number of phagocytosed bacteria was
counted using Synergy HT fluorimeter (BioTek) with 485620 nm
excitation and 528620 emission filters. Background correction
was done for autofluorescence.
Scanning electron microscopy (SEM). SEM was used to
study morphology. AECII and AM cells were plated on collagen
coated coverslips in 24-well plates. The cells were fixed in
Karnovsky’s fixative overnight, dehydrated by sequential alcohols,
sputter coated with gold – palladium and images taken at 100006
magnification.
Lung edema. After infection, lungs were removed from the
thoracic cavity, and the inferior third of the left lung were weighed
and then placed in a drying oven at 90uC for 24 h. The specimen
was reweighed, and the ratio of the weight before and after drying
calculated.
Lipid peroxidation assay. Malondialdehyde (MDA) is an
end product of lipid peroxidation process, and was measured in a
colorimetric assay (Calbiochem, San Diego, CA) according to the
manufacturer’s instructions. Homogenized lung tissue in 62.5 mM
Tris-HCL (pH=6.8) supplemented with Complete-Mini Protease
Inhibitor (Roche Diagnostics) in equal protein amounts were used
in the assay.
Lung myeloperoxidase (MPO) assay. MPO assay was
performed as described [44]. Samples were homogenized in
50 mM hexadecyltrimethylammonium bromide (HTAB) 50 mM
KH2PO4, pH 6.0, and 0.5 mM EDTA, 1 mL/100 mg tissue and
centrifuged for 15 min at 12000 rpm at 4uC. Supernatants were
decanted and 100 ml of reaction buffer (0.167 mg/mL O-
dianisidine, 50 mM KH2PO4, pH 6.0 and 0.0005% mM H2O2)
was added to 100 ml sample. Absorbance was read at 460 nm at
2 min intervals.
H2DCF Assay for Superoxide production. H2DCF dye
(Molecular Probes) does not normally fluoresce and emits green
fluorescence upon reaction with superoxide inside cells[45]. Cells
were treated as above and equal amount(s) of dye added.
Fluorescence was measured after 10 min incubation using the
fluorimeter (BioTek, in our laboratory). For confirmation, NBT
assay was used as we described previously [17].
siRNA. A pool of four specific siRNAs or sense controls was
(‘A pool’ is singular) purchased from Dharmacon (West Lafayette,
Colorado) to deplete Lyn in MLE-12, AECII and MSH cells and
the depleted expression assessed as we previously described [17].
Statistical analyses. Comparison of test with controls was
done in triplicates and the results were analyzed using two tailed
Student’s t test with a P value,0.05. For multiple groups with an
equal variance, we performed one-way ANOVA. For analyzing
image data the sample size was increased by taking pictures of at
least 100 cells per sample.
Supporting Information
Figure S1 AECII cells activate macrophages after PAO1
infection. Actin polymerization was induced by the medium from
A549 cells infected by PAO1 in the Boyden chamber, which has
two compartments separated by a porous membrane. RAW264
cells were seeded in the top and A549 cells in the bottom. Infection
of A549 cells was done separately before inoculation into the
chamber. Migrating cells were identified by staining the porous
membrane with rhodamine phalloidin for actin and DAPI for
nucleus and images taken by Zeiss confocal microscope. RAW264
cells started migrating towards infected A549 cells within 30 min
(A). Quantification of actin cytoskeletal changes in RAW264 cells
upon infection (B). RAW264 cells were grown on coverslips in 24
well plate. Cells were infected with PAO1 at 1:10 ratio for 1 h.
The cells were fixed in 4% PFA and stained with FITC CT (Lipid
raft marker) and Rhodamine Phalloidin (Actin). Untreated
controls showed more number of cells (52%) with cytoskeletal
changes like lamellipodium formation. The graph shows percent
positive for cytoskeletal changes and error bar denotes standard
deviation (P,0.01). AM conditioned medium has less potential for
attracting AM than the conditioned medium from AECII by
determining the migration index (C). Percentage of the migration
of treated samples against total cells counted.
Found at: doi:10.1371/journal.pone.0004891.s001 (1.33 MB TIF)
Figure S2 MCP-1 secreted by MLE-12 or isolated AECII is a
major chemokine by PAO1 infection. MCP-1 expression is
induced in MLE-12 cells by PAO1 infection. Lyn siRNA and
various inhibitors (PP2 and Rac1 inhibitor, Calbiochem) decrease
the expression of MCP-1 (A). AM under infection show less
secretion of MCP-1 than AECII cells. Also, additional inhibitors
examined demonstrate inhibition of MCP-1 expression in AM and
AECII cells. In addition, co-culturing of AM with AECII induces
increased secretion of MCP-1 than either cell alone (B).
Found at: doi:10.1371/journal.pone.0004891.s002 (1.16 MB TIF)
Figure S3 Activated AECII demonstrate increased immunolog-
ical characteristics including class II expression under PAO1
infection (A). Immunological markers including IL-12R (FITC)
and IL-17R (TRITC) are increased against controls (not shown)
under PAO1 infection (B) (all antibodies obtained from Santa Cruz).
Found at: doi:10.1371/journal.pone.0004891.s003 (1.59 MB TIF)
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